Inhibition of EGFR-induced glucose metabolism sensitizes chondrosarcoma cells to cisplatin (Q39002643)

8 September 2017

title

Inhibition of EGFR-induced glucose metabolism sensitizes chondrosarcoma cells to cisplatin (English)

1 reference

8 September 2017

1 reference

Yin-dong Song

1

1 reference

8 September 2017

Ke-fei Zhang

2

1 reference

8 September 2017

Dong Liu

3

1 reference

8 September 2017

Yan-qi Guo

4

1 reference

8 September 2017

Da-yong Wang

5

1 reference

8 September 2017

Ming-yu Cui

6

1 reference

8 September 2017

Gang Li

7

1 reference

8 September 2017

Yuan-xin Sun

8

1 reference

8 September 2017

Jian-hui Shen

9

1 reference

8 September 2017

Xin-gang Li

10

1 reference

8 September 2017

Long Zhang

11

1 reference

8 September 2017

Feng-jun Shi

12

1 reference

8 September 2017

publication date

21 April 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

35

1 reference

8 September 2017

issue

7

1 reference

8 September 2017

page(s)

7017-7024

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-014-1902-4

8 September 2017

exact match

0 references

cites work

The clinical approach towards chondrosarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1902-4

Curing metastatic testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1902-4

Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1902-4

FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1902-4

Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1902-4

Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1902-4

Molecular mechanisms of cisplatin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1902-4

PDCD5 promotes cisplatin-induced apoptosis of glioma cells via activating mitochondrial apoptotic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1902-4

Review of epidermal growth factor receptor biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1902-4

Survival of cancer cells is maintained by EGFR independent of its kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1902-4

Cisplatin-induced activation of the EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1902-4

ONCOMINE: a cancer microarray database and integrated data-mining platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1902-4

A review of erlotinib--an oral, selective epidermal growth factor receptor tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1902-4

Functional profiling of receptor tyrosine kinases and downstream signaling in human chondrosarcomas identifies pathways for rational targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1902-4

2-Deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1902-4

A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1902-4

SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1902-4

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1902-4

Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1902-4

Overexpression of pyruvate dehydrogenase kinase 3 increases drug resistance and early recurrence in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1902-4

Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses

21 January 2018

1 reference

12 December 2020

Concomitant weekly cisplatin and radiotherapy for head and neck cancer

1 reference

12 December 2020

Risk factors for survival and local control in chondrosarcoma of bone

1 reference

12 December 2020

Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistance

1 reference

12 December 2020

Inhibition of LDH-A by oxamate induces G2/M arrest, apoptosis and increases radiosensitivity in nasopharyngeal carcinoma cells

1 reference

12 December 2020

10.1007/S13277-014-1902-4

Identifiers

DOI

1 reference

8 September 2017

1 reference